
Originally Posted by
LATS60
All AAS's increase IGF I and bioavailability by binding to IGF I receptors, increasing RNA's that translate to increased protein and glycogen synthesis and inhibition of catabolism.
AAS have a direct (androgen receptors) and indirect (IGF I receptors) effect on the genetic machinery, this is called the double receptor effect and acts synergistically to promote increased skeletal muscle mass.
Orals have no greater effect in doing this than any other AAS as far as i'm aware.